Compare Abbott Laboratories (ABT) vs Devon Energy Corp (DVN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Devon Energy Corp — how do they compare? Abbott Laboratories trades at $95.59 (market cap $166.94B), while Devon Energy Corp trades at $42.99 (market cap $48.92B). The key difference: Abbott Laboratories is far larger — about 3.4× Devon Energy Corp's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | DVN | |
|---|---|---|
Market Cap | $166.94B | $48.92B |
Sector | Health | Energy |
52-Week High | $136.62 | $52.07 |
52-Week Low | $82.57 | $31.74 |
Enterprise Value | $193.69B | $55.69B |
Dividend Yield | 2.63% | 2.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Devon Energy (DVN) trades at $42.41, up 4.79% on the day, with a bearish technical signal but bullish oscillators. The stock shows strong profitability with a 13.71% net margin and trades at a P/E of 11.24, below sector averages. Recent news highlights activist pressure for asset sales and a pending Q2 2026 earnings report on August 4, 2026.
DVN presents a value opportunity with a consensus price target of $61.60, implying 45% upside, supported by a 71% buy rating from analysts. Risks include oil price volatility, execution of the Coterra merger synergies, and activist investor demands. The company's disciplined capital allocation and strong cash flow generation underpin the bullish outlook.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →
